The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis [version 1; peer review: 2 approved]
Pulmonary arterial hypertension, categorized as group 1 pulmonary hypertension by the World Health Organization classification system, represents a major complication of systemic sclerosis resulting from pulmonary vascular involvement of the disease. The high mortality seen in systemic sclerosis-ass...
Main Authors: | Michael H Lee, Todd M Bull |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-12-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-2124/v1 |
Similar Items
-
Recent advances in pulmonary arterial hypertension [version 1; referees: 2 approved]
by: Martin R. Wilkins, et al.
Published: (2018-07-01) -
Experiences with treprostinil in the treatment of pulmonary arterial hypertension
by: Amanda R. Stream, et al.
Published: (2012-10-01) -
Recent advances in the management of pulmonary arterial hypertension [version 1; referees: 2 approved]
by: Halley Tsai, et al.
Published: (2016-11-01) -
The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension
by: Meng-Chien Willie Hsieh, et al.
Published: (2022-06-01) -
The network structure of depressive symptomatology in Peruvian adults with arterial hypertension [version 3; peer review: 2 approved]
by: Cristian Ramos-Vera, et al.
Published: (2022-03-01)